Palisade Bio Inc (NASDAQ:PALI) shares, rose in value on Wednesday, June 18, with the stock price down by -0.54% to the previous day’s close as strong demand from buyers drove the stock to $0.64.
Actively observing the price movement in the last trading, the stock closed the session at $0.64, falling within a range of $0.635 and $0.6626. The value of beta (5-year monthly) was 1.342. Referring to stock’s 52-week performance, its high was $5.15, and the low was $0.60. On the whole, PALI has fluctuated by -6.92% over the past month.
With the market capitalization of Palisade Bio Inc currently standing at about $3.07 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PALI’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PALI currently trading nearly -9.67% and -11.22% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.52, while the 7-day volatility ratio is showing 5.35% which for the 30-day chart, stands at 4.98%. Furthermore, Palisade Bio Inc (PALI)’s beta value is 1.38, and its average true range (ATR) is 0.06.
A comparison of Palisade Bio Inc (PALI) with its peers suggests the former has fared considerably weaker in the market. PALI showed an intraday change of -0.54% in last session, and over the past year, it shrunk by -86.20%%.
Data on historical trading for Palisade Bio Inc (NASDAQ:PALI) indicates that the trading volumes over the past 10 days have averaged 0.7 and over the past 3 months, they’ve averaged 286.24K. According to company’s latest data on outstanding shares, there are 4.80 million shares outstanding.
Nearly 0.81% of Palisade Bio Inc’s shares belong to company insiders and institutional investors own 5.43% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.23 million shares as on 2025-05-30, resulting in a short ratio of 0.54. According to the data, the short interest in Palisade Bio Inc (PALI) stood at 478.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 40926.0. The stock has fallen by -61.18% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PALI stock heading into the next quarter.
